Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
46.02
-0.38 (-0.82%)
Nov 21, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$86.79
Upside
+88.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 | Strong Buy | Maintains | $121 | +162.93% | Nov 12, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $109 → $121 | Strong Buy | Maintains | $109 → $121 | +162.93% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +67.32% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +152.06% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $82 → $95 | Strong Buy | Maintains | $82 → $95 | +106.43% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +152.06% | Oct 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $61 → $73 | Strong Buy | Maintains | $61 → $73 | +58.63% | Oct 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +152.06% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +67.32% | Sep 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +152.06% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +152.06% | Sep 16, 2024 |
| Barclays | Barclays | Buy Maintains $83 → $81 | Buy | Maintains | $83 → $81 | +76.01% | Aug 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $72 → $75 | Buy | Maintains | $72 → $75 | +62.97% | Aug 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $67 → $76 | Strong Buy | Maintains | $67 → $76 | +65.15% | Aug 2, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $115 → $116 | Buy | Maintains | $115 → $116 | +152.06% | Aug 2, 2024 |
| Wedbush | Wedbush | Hold Maintains $43 → $46 | Hold | Maintains | $43 → $46 | -0.04% | Aug 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.